D
Recursion Pharmaceuticals, Inc. RXRX
$4.94 $0.163.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 33.34% 6.89% -58.26% 147.62% 30.86%
Total Other Revenue -- -- -- -- --
Total Revenue 33.34% 6.89% -58.26% 147.62% 30.86%
Cost of Revenue 79.00% 92.39% 40.02% 7.16% 29.00%
Gross Profit -88.58% -110.56% -55.66% 13.86% -28.61%
SG&A Expenses 46.56% 74.00% 144.25% 29.31% 12.52%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 70.02% 87.15% 69.74% 13.04% 23.97%
Operating Income -75.28% -98.64% -83.66% 1.20% -23.04%
Income Before Tax -75.29% -119.90% -84.32% -2.86% -27.81%
Income Tax Expenses -- 79.72% 100.17% -- --
Earnings from Continuing Operations -76.23% -121.60% -92.38% -3.04% -27.13%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -76.23% -121.60% -92.38% -3.04% -27.13%
EBIT -75.28% -98.64% -83.66% 1.20% -23.04%
EBITDA -66.40% -93.38% -84.65% 0.89% -20.22%
EPS Basic -2.28% -29.86% -27.77% 21.84% -5.72%
Normalized Basic EPS -1.70% -28.89% -20.97% 21.98% -6.30%
EPS Diluted -2.28% -29.86% -28.41% 21.66% -5.72%
Normalized Diluted EPS -1.70% -28.89% -20.97% 21.98% -6.30%
Average Basic Shares Outstanding 72.32% 70.65% 50.58% 31.85% 20.25%
Average Diluted Shares Outstanding 72.32% 70.65% 50.58% 31.85% 20.25%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --